2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents.

导出原文传递

翻译打印收藏纠错

第一作者： Karin,Jordan

第一单位： Department for Hematology/Oncology, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120, Halle, Germany. karin.jordan@uk-halle.de.

作者： Karin,Jordan ^[1] ; Alexandre,Chan ^[2] ; Richard J,Gralla ^[3] ; Franziska,Jahn ^[4] ; Bernardo,Rapoport ^[5] ; David,Warr ^[6] ; Paul J,Hesketh ^[7]

作者单位： Department for Hematology/Oncology, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120, Halle, Germany. karin.jordan@uk-halle.de. ^[1] Department of Pharmacy, National University of Singapore, 21 Lower Kent Ridge Rd, Singapore, Singapore. ^[2] Albert Einstein College of Medicine, Bronx, New York, USA. ^[3] Department for Hematology/Oncology, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120, Halle, Germany. ^[4] Medical Oncology Centre of Rosebank, Johannesburg, South Africa. ^[5] Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. ^[6] Lahey Hospital & Medical Center, Burlington, MA, USA. ^[7]

关键词 Antineoplastic agents Emetogenicity Nausea Risk classification Vomiting